Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kyndryl Holdings Inc (KD) vs Zoetis Inc (ZTS) Price & Performance

Kyndryl Holdings IncTrade
Zoetis IncTrade

Price performance (Past 24H)

Key statistics

Kyndryl Holdings Inc vs Zoetis Inc — how do they compare? Kyndryl Holdings Inc trades at $12.74 (market cap $2.91B), while Zoetis Inc trades at $72.43 (market cap $31.14B). The key difference: Zoetis Inc is far larger — about 10.7× Kyndryl Holdings Inc's market cap, and Zoetis Inc pays a 2.81% dividend while Kyndryl Holdings Inc pays none. Which is the better fit depends on your goals.

KDZTS
Market Cap
$2.91B$31.14B
Sector
TechnologyHealth
52-Week High
$33.14$156.76
52-Week Low
$10.59$71.91
Enterprise Value
$5.74B$38.70B
Dividend Yield
2.81%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Kyndryl Holdings Inc

Kyndryl (KD) trades at $13.63, down 2.78% today, with a mixed technical picture showing bullish moving averages but neutral oscillators. Fundamentally, the company shows improving profitability with 2025 net income of $252M after years of losses, though recent Q1 2027 earnings missed expectations. The acquisition of Healthcare IT Leaders and new AI services demonstrate strategic growth initiatives.

While analyst consensus leans Hold (71%) with a $13.50 price target near current levels, improving cash flow and debt management provide stability. Key risks include revenue declines, ongoing investigations, and competitive pressures in IT services. The stock presents a turnaround story with moderate upside potential balanced by execution risks.

Zoetis Inc

Zoetis (ZTS) trades at $74.86, up 3.03% today but facing bearish technical signals with 16 sell indicators. The company reported mixed Q2 2026 results, beating EPS estimates but missing revenue expectations, while cutting full-year guidance due to softer pet healthcare demand. Strong fundamentals include a 27.69% net margin and 64.91% ROE, though valuation metrics show a P/E of 12.29 and P/S of 3.41.

The stock presents a value opportunity with analyst consensus target of $94.90 (27% upside), but faces near-term headwinds from competitive pressures and class action lawsuits. Investors should weigh strong profitability against slowing growth in companion animal segments and technical bearishness.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Kyndryl Holdings Inc

Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives.

Read more on KD

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Read more on ZTS